Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bb487f05f60dff7eef546f367f37e90c6> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bb487f05f60dff7eef546f367f37e90c6 NCIT_P378 "NCI" @default.
- Bb487f05f60dff7eef546f367f37e90c6 type Axiom @default.
- Bb487f05f60dff7eef546f367f37e90c6 annotatedProperty IAO_0000115 @default.
- Bb487f05f60dff7eef546f367f37e90c6 annotatedSource NCIT_C131178 @default.
- Bb487f05f60dff7eef546f367f37e90c6 annotatedTarget "The camsylate salt form of rucaparib, an orally bioavailable tricyclic indole and inhibitor of poly(ADP-ribose) polymerases (PARPs) 1 (PARP1), 2 (PARP2) and 3 (PARP3), with potential chemo/radiosensitizing and antineoplastic activities. Upon administration, rucaparib selectively binds to PARP1, 2 and 3 and inhibits PARP-mediated DNA repair. This enhances the accumulation of DNA strand breaks, promotes genomic instability and induces cell cycle arrest and apoptosis. This may enhance the cytotoxicity of DNA-damaging agents and reverse tumor cell resistance to chemotherapy and radiation therapy. PARPs are enzymes activated by single-strand DNA breaks that catalyze the post-translational ADP-ribosylation of nuclear proteins, which induces signaling and the recruitment of other proteins to repair damaged DNA. The PARP-mediated repair pathway plays a key role in DNA repair and is dysregulated in a variety of cancer cell types." @default.